Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops

May 06, 2022

Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops

Authors: William G Gensheimer, David M Kleinman, Mithra O Gonzalez, Deepak Sobti, Eugene R Cooper, Gerard Smits, Andrew Loxley, Mark Mitchnick, James V Aquavella


Abstract


Purpose: To evaluate the effectiveness of glycerin 1% formulated with the novel and proprietary ophthalmic excipient poly(l-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG) (Eyeon Particle Sciences LLC) in extending tear film break-up time (TFBUT) compared with a market-leading artificial tear formulation of propylene glycol (0.3%) and polyethylene glycol (0.4%) (Systane(®) Lubricant Eye Drops; Alcon, Fort Worth, TX).


Methods: This prospective single-center, single visit, randomized, double-masked exploratory trial compared the new formulation and Systane using TFBUT. Noninvasive break-up time (NIBUT) was measured in subjects with asymptomatic to mild (n=5), mild to moderate (n=5), and moderate to severe (n=6) dry eye disease using the TearscopePlus™ at pre-instillation and again at 15, 30, 60, and 120 min after instillation. Fluorescein break-up time (FBUT) was measured at 120 min after instillation.


Results: At 15 min (N=16), the new formulation extended mean NIBUT by 14.67 s (P=0.05) compared with 7.40 s (P=0.34) by Systane. The new formulation had a mean FBUT of 4.92 s longer than Systane at 120 min (P=0.12). With outliers removed (N=13), the difference between the mean NIBUT change from baseline for the new formulation and Systane at 120 min was statistically significant (P=0.03).


Conclusions: This study demonstrates that PLL-g-PEG as a polymer excipient in artificial tears is effective in improving the performance of demulcents to significantly prolong NIBUT at 15 min, and that protective activity from this artificial tear product for 2 or more hours after eye drop instillation is possible.


Link: https://pubmed.ncbi.nlm.nih.gov/22554205/


ophthalmologist vs optometrist
31 Jan, 2024
Decide between Ophthalmologist and Optometrist with our guide. Find the right eye care professional for your needs. Make informed choices today.
macular degeneration
10 Jan, 2024
Uncover the nuances of Macular Degeneration. Learn about age-related vision loss, symptoms, and effective management strategies for clearer sight.
Managing Glaucoma Risks with Diabetes
14 Dec, 2023
Explore a comprehensive guide on managing glaucoma risks with diabetes. Learn about diabetic retinopathy, vision care, and the impact of diabetes on eye health.
eye drop guide
19 Oct, 2023
Dry eyes? Get relief with the right eye drops. Learn how to find the right solution to soothe your discomfort and enjoy clearer, more comfortable vision.
light adjusted lens
18 Aug, 2023
Discover clear vision and comfort with Light Adjustable Lenses (LAL) for Presbyopia in Waxahachie, Texas. Experience a brighter future for your eyesight.
adjustable contact lenses
01 Aug, 2023
Learn more about Texas' revolutionary Light Adjustable Lenses (LALs), which offer customized vision correction like never before. See how LAL is revolutionizing vision correction.
icl vision correction
10 Jul, 2023
EVO ICL (Implantable Collamer Lens) offers advanced vision correction. Learn about its benefits, safety, and effectiveness in correcting refractive errors.
glaucoma vision
By Shyam Kumarm 01 Jun, 2023
Glaucoma is a group of eye diseases that damage the optic nerve and can lead to vision loss. This article discusses the causes, symptoms, and treatment options for glaucoma.
26 May, 2023
Discover customizable cataract surgery options with light adjustable lens by RxSight. Dr. Deepak Sobti at Texas eye and cataract clinic unlocks precision vision.
Latest Ringless IOLs for Extended Depth of Focus
26 May, 2023
Discover the latest ringless IOLs for extended depth of focus at Texas Eye and Cataract Clinic, introduced by Dr. Deepak Sobti. Enhance your vision today.
More Posts
Share by: